Will this good progress news cause a short squeeze?

https://www.cassavasciences.com/static-files/d46ee533-09d3-42d8-ba76-5b62d9332720#page4

Reposted from Stocktwiitts-Zack’s report from last week:
https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_10012024_CTSO_Kerr.pdf

Under the Freedom of Information Act one can retrieve some of the DOD filings of progress under CTSO Award W81XWH-22-C-0046.
In a recent April 2024 filing statement by Dr. Maryann Gruda she stated:
"Greater availablilty of universal plasma products wil significantly simplfy logistics and reduce costs for both military and civilian transfusion services. Phase II SBIR studies perfomred at WRNMMC showed the BGA-Absorber prototype removed anti-A-titer and anti-B titers by 99% from high titer human plasma, without affecting coagulation factors. Building on these exciting results, our proposed efforts are directed towards combining BGA reduction with spray or freeze-drying efforts to generate universal dried plasma that is suitable and readily available under austere conditions".
The May filing actually shows how the product packaging would work.

In many ways this opporunity seems much lager, more profitable and sooner benefit to shareholders than current FDA approvals underway.
Why is Dr. Chan not talking about this?
Maybe to some investors looking at the new Jefferies $20 million raise?
Looking forward to additional filings.
Maybe a major medical device company like Boston Scientfic or Medtronic could swoop in, buy CTSO under an unfriedly tender for $60-80 milion, fire the Board and all the overhead people, keep the new manufacturing facility and use their own global distribution to quickly build a $200-500 million annual business (with 75% plus gross margins) selling to every naval ship, cruise ship, amubulance, EMS, police and fire fleet?

Company files $150 million effectiveness prospectus today;
https://www.sec.gov/Archives/edgar/data/1175151/000110465924103199/tm2424757d1_s3a.htm#sp1-001
Delusinal management? This is almost TWICE the total market capitalization of company!

Officially Dead?:
1 igen_1512g.htm 15-12G
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 333-141875
IGEN Networks Corp.
(Exact name of registrant as specified in its charter)

28375 Rostrata Ave., Lake Elsinore, CA 92532
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)
?

Rule 12g-4(a)(2)
?

Rule 12h-3(b)(1)(i)
?

Rule 12h-3(b)(1)(ii)
?

Rule 15d-6
?

Rule 15d-22(b)
?

Approximate number of holders of record as of the certification or notice date: 149

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: July 31,2024
By:
/s/ Neil Chan

Name: Neil Chan


Title: CEO, Director

"On May 8, 2024, we dismissed BFBorgers Certified Public Accountants (“BFBorgers”) as our company’s independent principal accountant to audit the Company’s financial statements. The decision to change accountants was approved by our board of directors. Our company does not have a standing Audit Committee."
-Recent SEC filing.

Unfortunately they have not been able to get approval for a broad sepsis treatment. 7-8 years ago they had research grant and hired a research team at University of Pittsburgh. It failed to prove a broad solution so they pivoted to much narrower applications.

Some think Chan and their scientific team made a HUGE blunder in not accelerating their HemoDefend application ( also under $15 million + grants) with Department of Defense to provide a kit to take any blood type , run it through a special cartridge bag, and create a UNIVERSAL blood plasma. A HUGE global market to be carried in every ambulance , EMS vehicles, naval ships, cruise ships etc. could be easily manufactured in their new NJ facility. Easily a $300-400 million global market annually within 2years of introduction with 85% gross margins. DOD wants a freeze dried version which is being worked on. IMHO this product would get FDA approval relatively quickly and would save the company and easily move the stock to $7-10. Chan has tied his fortune and that of the company to a weaker opportunity. CFO has left with handwriting on the wall. A shame.
After they run out of cash whoever acquires CTSO assets and intellectual property on this product line will make a fortune. There are several medical device companies with great balance sheets and superb global marketing/sales forces waiting in the wings to scoop up the carcass Chan will leave in 18 months.

Could he be selling his house and getting out of town?
https://www.redfin.ca/bc/oak-bay/1075-St-David-St-V8S-4Y7/home/155865061

Neil Chan here at IGEN and Phil Chan at CTDO have both destroyed a tremendous amount of shareholder capital through bad choices and mismanagement. Board a disaster

Phil Chan here at CTSO and Neil Chan at IGEN have both destroyed a tremendous amount of shareholder capital through bad choices and mismanagement. Board a disaster.

September 9 presentation before Goldman Sachs institutional audience should be a positive.

SOFI presentation and update at September 9 Goldman Sachs Conference should contain further updates on broadening revenue sources and maybe some new relationships if concluded by then…IMHO

Why are you sticking. With E Trade?

Nasdaq coming for them in new purge?
https://www.wsj.com/finance/stocks/nasdaq-penny-stock-proposed-rule-change-74677b00?st=9d6hc8olx75pnon&reflink=article_copyURL_share

Nasdaq purge:
https://www.wsj.com/finance/stocks/nasdaq-penny-stock-proposed-rule-change-74677b00?st=9d6hc8olx75pnon&reflink=article_copyURL_share

A reminder from today's 10K SEC filing:
Pursuant to an agreement dated August 11, 2003, an existing investor agreed to make a $4 million equity investment in the Company. These amounts were received by the Company in 2003. In connection with this agreement the Company granted the investor a perpetual royalty of 3% on all gross revenues received by the Company from the sale of its CytoSorb device which such rights were assigned to an existing investor in 2017. For the three months ended June 30, 2024 and 2023, the Company recorded royalty expenses of approximately $264,000 and $240,000, respectively. For the six months ended June 30, 2024 and 2023, the Company recorded royalty expenses of approximately $531,000 and $474,000, respectively. These expenses are included in selling, general and administrative expenses in the consolidated statements of operations and comprehensive loss.

The con is finally dead,sealed and removed.
The press releases and management presentations presented delusional dreams.Few questioned after two Directors resigned and Chan also apparently took over as CFO. Watch for his next act!

A lot of factual dirts comes out in divorce

Ex wife??

The Canadians know his hone address and are watching

SO what was truth and BS promo
https://www.prnewswire.com/news-releases/igens-ceo-provides-progress-update-on-key-initiatives-for-2021-positioned-for-growth-and-market-leadership-301328943.html

Do not want any defenders interferring, Canadaians duped have been waiting 7 yeras, Come to the court earings next year

At least file-3 in Canada and 1 in U.S. in hopper , lawyers no doubt take on contingency, patent value promoted and limited value.. , poor tax withholding, issuing or statement and never following up, late tax filings all in the queue? But in the end he and wife have no visible assets? Probably could be barred from entering U.S. We in Canada who got conned by hiim z7? years ago always on the look out. He is done band unfortunately his wife and son will pay the reputational price even with nsme changes.First in perdon court hearing could see big brown turb out

Several--have to use addreess
1075 St. David Street
Victoria,,Canada V854y7
assets lke house and boat probbaly moved into first wife name so use Heather and Neil Chan on any filing

You are not needed.Already several dozen have written directly. Hearther and Neil are gone. Neighbors also scammed so their futures are probably not going to raise stock funds again

Chan is SGT -on social media photos

You can find them both hiding out at
1075 St. David Street
Victoria, Canada V854Y7

Total BS … Abel gone? Chan barred from U.S. ? Pending lawsuit will keep him in Canada?? U.S. office closing??

“we are flush with anecdotal evidence ‘“

Where can we see these?

The new SEC filing today
https://www.cassavasciences.com/sec-filings/sec-filing/8-k/0001493152-24-025725
does REVEAL THAT A SECOND EMPLOYEE IS UNDER INVESTIGATION but does not reveal the name.
This seems MATERIAL?
If it is Dr. Burns then real concerns??

No statement indicating the company was accused of anything ?!

Who are the competitors to worry about?
Anything proprietary here?

Too little too late. Cash crunch is the challenge. Their distribution model through third parties in 60 countries brings in zilch!!

SEC 144 filing would/will show if Chan ( SGT) is out or still a shareholder….

What will next eventual filing show ? Has Board resigned? Did they dump their shares? Has Chan run back to Canada? Or could one of the press releases come true and they get some revenues? Will the new accounting firm get paid and get caught up? Will some one make a documentary about it the Chan con man?

No new accounts no new revenues no positive follow up on the bs public press releases-you are naive to keep believing the con man IMHO

Is it possible part of problem is trying to get an accounting firm to do business with them given balance sheet and lack of revenues?

soooo--what ever happened with this? No new client account revenues so far.. No follow up annoucements.. Was this just more PR BS??

Reposted from X:
Rapport Therapeutics filed an S1 on May 17th to go public.

The genesis of Rapport Therapeutics is unequivocally linked to an effort to stop the Cassava Sciences Alzheimer's therapy trial. They seemed to put a competitor through HELL to gain an advantage and profit from a short position in the stock.

David Bredt founded Rapport Therapeutics a Delaware on February 11 2022, the same day that his citizen's petition against $sava was denied by the FDA.

I believe David Bredt,
@JNJNews
, Rapport Therapeutics, Jordan Thomas, and
@ThirdRockV
participated in a massive fraud to stop a competitor in the exact same research area of Receptor Associated Proteins (the RAP in Rapport). David Bredt departed Johnson and Johnson in March of 2021. He worked with Jordan Thomas and filed a Citizen's Petition and Whistleblower complaints against Cassava in August of 2021. The Citizen's Petition was denied on the same day he started Rapport. SEC and DOJ investigations still linger with no charges against $sava. How could that happen if all these events are not linked by collusion between these people and companies?

Sorry—do not understand your question.
Good luck